Outcome of Infants at Risk of Brain Damage after Katona Neurohabilitation TherapyThalía Harmony*
Universidad Nacional Autonoma de Mexico, Instituto de Neurobiología, Querétaro, Mexico
- Corresponding Author:
- Thalía Harmony
National Autonomous University of Mexico
Institute of Neurobiology, Department of Behavioral and Cognitive Neurobiology
Boulevard Juriquilla 3001, Vacation Specials 76230, Querétaro, Mexico
Ext. 113; 52-442-3527773
Fax: 52 442 2381005
E-mail: [email protected]
Received date: June 14, 2017; Accepted date: June 28, 2017; Published date: August 05, 2017
Citation: Harmony T (2017) Outcome of Infants at Risk of Brain Damage after Katona Neurohabilitation Therapy. Int J Neurorehabilitation 4:277. doi:10.4172/2376-0281.1000277
Copyright: © 2017 Harmony T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: To evaluate Katona’s neurorehabilitation therapy in preterm and term infants with risk factors for brain damage followed up to 24 months of age. Methods: 262 infants from 25 to 40 weeks of gestational age (GA) were treated with neurohabilitation beginning before 2 months of corrected age. Treatment was intensive, sustained for at least 12 months and required family participation. Neuropediatric examinations, MRI and Bayley-II scales were performed. Results: Abnormal MRI findings were observed in 80% of infants (increase in lateral ventricle volumes, decrease in corpus callosum volume, diffuse and cystic periventricular leukomalacia, diffuse white matter abnormalities, haemorrhages, infarcts). Outcome: Bayley-II scales showed that 20% of infants with a GA of less than 29 weeks and less than 15% of infants with a 30-40 week GA had significantly delayed MDI and PDI scores. Conclusion: Diagnosis and treatment using neurohabilitation in new-borns at risk of brain damage is recommended.